Surface Oncology, Inc. announced the appointment of the F. Stephen Hodi, MD to the company’s scientific advisory board (SAB). Dr. Hodi is Director of the Melanoma Center and the center for Immuno-Oncology at Dana-Farber/Brigham and Women’s Cancer Center, the Sharon Crowley Martin Chair in Melanoma at Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School.